[논문]Factors Influencing Discrepancies Between the QuantiFERON-TB Gold in Tube Test and the Tuberculin Skin Test in Korean Patients with Rheumatic Diseases

Kim, J.H.; Cho, S.K.; Han, M.; Choi, C.B.; Kim, T.H.; Jun, J.B.; Bae, S.C.; Yoo, D.H.; Sung, Y.K.

doi:10.1016/j.semarthrit.2012.07.001

Factors Influencing Discrepancies Between the QuantiFERON-TB Gold in Tube Test and the Tuberculin Skin Test in Korean Patients with Rheumatic Diseases

Seminars in arthritis and rheumatism, v.42 no.4, 2013년, pp.424 - 432

Kim, J.H. , Cho, S.K. , Han, M. , Choi, C.B. , Kim, T.H. , Jun, J.B. , Bae, S.C. , Yoo, D.H. , Sung, Y.K.

Abstract ▼ AI-Helper

Objectives: To estimate the positivity and agreement between QuantiFERON-tuberculosis (TB) gold in tube test (QFT-GIT) and tuberculin skin test (TST) according to underlying rheumatic diseases and to identify the influencing factors on discrepancies between the 2 tests. Methods: Among the 757 patients who underwent both QFT-GIT and TST simultaneously from September 2008 to November 2010, patients with indeterminate QFT-GIT results (n = 21), with active (n = 11) or suspicious (n = 1) findings for tuberculosis on a chest radiograph, were excluded. Finally, 724 patients were recruited for this study: 497 patients with rheumatoid arthritis (RA), 198 with ankylosing spondylitis (AS), and 29 with juvenile rheumatoid arthritis (JRA). The agreement between the 2 tests was estimated by Cohen's κ and factors influencing discrepancies were identified using multivariate analysis. Results: The positivity of QFT-GIT was higher in RA than AS or JRA (30.2%, 16.2%, and 3.4%, respectively). In contrast, TST positivity was highest in AS compared to RA and JRA (45.5%, 28.2%, and 17.2%, respectively). The agreement between the 2 tests was low in all patients (κ = 0.285). The only predictor of a discrepancy between the 2 tests was older age. Factors associated with discordant QFT-GIT-negative/TST-positive results were female [odds ratio (OR) = 2.33, confidence interval (CI) 1.11 to 4.89] and AS (OR = 3.12, CI 1.44 to 6.79), whereas a discordant QFT-GIT-positive/TST-negative result was associated with glucocorticoid use (OR = 2.44, CI 1.24 to 4.81). Conclusions: The agreement between the 2 tests is low; therefore, it would be better to perform both tests than to use any 1 test alone for the detection of LTBI in TB-endemic regions. Female and underlying AS are related to being QFT-GIT-negative/TST-positive, and the use of glucocorticoid is associated with being QFT-GIT-positive/TST-negative.

주제어

참고문헌 (30)

Infect Dis Clin North Am Bouza 15 335 2001 10.1016/S0891-5520(05)70149-5 Infections in systemic lupus erythematosus and rheumatoid arthritis

상세보기
J Rheumatol Carmona 30 1436 2003 Increased risk of tuberculosis in patients with rheumatoid arthritis

상세보기
J Rheumatol Kim 38 2218 2011 10.3899/jrheum.110373 Incidence of tuberculosis among Korean patients with ankylosing spondylitis who are taking tumor necrosis factor blockers

상세보기
Rheumatology (Oxford) Kievit 50 196 2011 10.1093/rheumatology/keq325 Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: Results from the Dutch Rheumatoid Arthritis monitoring register

상세보기
Clin Microbiol Infect Moiton 12 1151 2006 10.1111/j.1469-0691.2006.01546.x Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections

상세보기
Nat Clin Pract Rheumatol Winthrop 2 602 2006 10.1038/ncprheum0336 Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

상세보기
Arthritis Res Ther Hamdi 8 R114 2006 10.1186/ar1994 Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

상세보기
J Infect Dis Saliu 194 486 2006 10.1086/505430 Tumor-necrosis-factor blockers: Differential effects on mycobacterial immunity

상세보기
Rheumatol Oxf Engl Ledingham 44 1205 2005 10.1093/rheumatology/kei103 British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-alpha treatments

상세보기
Ann Rheum Dis Mariette 62 791 2003 10.1136/ard.62.8.791 French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers

상세보기
Ann Rheum Dis Martin 69 181 2010 10.1136/ard.2008.101857 Comparison of interferon γ release assays and conventional screening tests before tumour necrosis factor α blockade in patients with inflammatory arthritis

상세보기
JAMA Kang 293 2756 2005 10.1001/jama.293.22.2756 Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

상세보기
J Clin Lab Anal Moon 25 382 2011 10.1002/jcla.20479 Latent tuberculosis infection screening for laboratory personnel using interferon-γ release assay and tuberculin skin test in Korea: An intermediate incidence setting

상세보기
Int J Occup Med Environ Health Talebi-Taher 24 359 2011 10.2478/s13382-011-0046-7 Comparing the performance of QuantiFERON-TB gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers

상세보기
MMWR Recomm Rep Mazurek 59 1 2010 Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States
Arthritis Rheum Carmona 52 1766 2005 10.1002/art.21043 Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

상세보기
Ann Rheum Dis Ponce de Leon 64 1360 2005 10.1136/ard.2004.029041 Attenuated response to purified protein derivative in patients with rheumatoid arthritis: Study in a population with a high prevalence of tuberculosis

상세보기
Clin Gastroenterol Hepatol Mow 2 309 2004 10.1016/S1542-3565(04)00060-6 High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy

상세보기
MMWR Recomm Rep 49 1 2000 Targeted tuberculin testing and treatment of latent tuberculosis infection
Lancet Infect Dis Pai 4 761 2004 10.1016/S1473-3099(04)01206-X Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review

상세보기
N Engl J Med Jasmer 347 1860 2002 10.1056/NEJMcp021045 Clinical practice

상세보기
Internist (Berl) Hoffmann 48 497 2007 10.1007/s00108-007-1827-8 Interferon-gamma release assays in tuberculosis diagnostics

상세보기
MMWR Recomm Rep Mazurek 52 15 2003 Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection
J Rheumatol Inanc 36 2675 2009 10.3899/jrheum.090268 Agreement between QuantiFERON-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis

상세보기
2009 Global tuberculosis control: Epidemiology, strategy, financing, WHO Report 2009
Int J Tuberc Lung Dis Hong 1998 2 27 1995 The seventh nationwide tuberculosis prevalence survey in Korea
Diagn Microbiol Infect Dis Chun 62 389 2008 10.1016/j.diagmicrobio.2008.08.022 The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Guerin vaccinated children

상세보기
JAMA Kang 293 2756 2005 10.1001/jama.293.22.2756 Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

상세보기
BMC Infect Dis Kim 9 207 2009 10.1186/1471-2334-9-207 Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population

상세보기
Am J Respir Crit Care Med Griffith 175 367 2007 10.1164/rccm.200604-571ST An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Factors Influencing Discrepancies Between the QuantiFERON-TB Gold in Tube Test and the Tuberculin Skin Test in Korean Patients with Rheumatic Diseases

Abstract ▼ AI-Helper

주제어

참고문헌 (30)

이 논문을 인용한 문헌

관련 콘텐츠

원문 URL 링크

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트